~~<i id='5FA1B5D375'><strike id='5FA1B5D375'><tt id='5FA1B5D375'><pre id='5FA1B5D375'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：fashion 2025-09-29 04:03:06 Page View：4637

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows.

On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

Bioluminescence joined at least four other firms — OrbiMed, Sofinnova Partners, Abingworth, and Revelation Partners — in announcing new pools of capital in the last two weeks. Together, they have raised $5.94 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Stroke rates rising, especially in working
Next article： The high cost of giving birth even with insurance

knowledge

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

ChineseWanxiongHuang,afreedivinginstructor,practiceshisskillsintheseaaroundBoholIslandinthePhilippin

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Trump team launching legal defense fund to help pay legal bills

2:42RepublicanpresidentialcandidateformerpresidentDonaldTrumpspeaksattheRepublicanPartyofIowa's2023L